Patrizia Cabazzoni, former director of the Food and Drug Administration Center’s Drug Evaluation and Research Center, will serve as Pfizer’s chief medical officer, the company announced Monday.

Cabazzoni Retirement From the FDA, just before President Trump took office in January. She is rejoining Pfizer after the past eight years of company stints to work in the industry she was in charge of regulation.

In her new role, Cabazzoni will “lead other medical functions, including Pfizer’s regulation, pharmacy, safety, epidemiology, and the generation of medical information and evidence,” the company announced in the press. release.

Physicians and leaders in the world of healthcare responded to X’s news and pointed to the “revolving door” between the pharmaceutical industry and the institutions that regulate it. (Related: RFK’s Maha forces descend from left, right and center in the national capital)

“Here’s how it works. Whether the evidence for FDA rubber stamp Pfizer drugs and vaccines is poor, or the FDA is pushing these products to children.”

“Then you’ll leave the FDA and get paid by Pfizer,” he continued. “This is corruption.”

This is how it works
Pfizer drugs and vaccines even when FDA rubber stamp evidence is bad
The FDA even pushes these products into kids (voxeltor)
The Caliph lies about Pfizer products
Voxeltor kills
After that, leave the FDA and receive payment from Pfizer
This is corruption @robertkennedyjr pic.twitter.com/ydci2zalni

– Vinay Prasad MD MPH (@vprasadmdmph) February 24, 2025

“This was the country’s top drug regulator last month,” tweeted Calley Means, co-founder of a political alliance with Robert F. Kennedy Jr., secretary of Health and Human Service.

This was the country’s top drug regulator last month.

I was hired immediately @scottgottliebmd pic.twitter.com/yizqmabpjz

– Calley Means (@CalleyMeans) February 24, 2025

“The revolving door between the FDA and Big Pharma will need to be closed,” added Dr. Ken Berry, a family doctor.

The revolving door between the FDA and Big Pharma must be closed. https://t.co/dyvym0ewwg

– Ken D Berry MD (@kendberrymd) February 24, 2025

Cavazzoni’s departure was before departmental selection, with thousands of workers from the FDA and HHS recently rejected.

She previously served under Trump during his first term. However, she is said to have been willing to ignore him. Cabazzoni said in 2020 that if Trump asked him to draft a list of her employees, she would send him a blank sheet of paper, people familiar with the matter would have him blank I said I’d send you a paper I said Politics.